RAJKUMAR VENKATRAMANI to Disease-Free Survival
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Disease-Free Survival.
Connection Strength
0.403
-
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30357.
Score: 0.093
-
Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials. Pediatr Blood Cancer. 2017 Jul; 64(7).
Score: 0.061
-
High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer. 2014 Aug; 61(8):1357-61.
Score: 0.050
-
Inflammatory myofibroblastic tumors in childhood. Pediatr Hematol Oncol. 2013 Oct; 30(7):640-5.
Score: 0.048
-
Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer. 2012 Sep; 59(3):493-8.
Score: 0.043
-
Supratentorial ependymoma in children: to observe or to treat following gross total resection? Pediatr Blood Cancer. 2012 Mar; 58(3):380-3.
Score: 0.040
-
Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction. Am J Pathol. 2022 06; 192(6):917-925.
Score: 0.022
-
Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
Score: 0.016
-
Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III. Pediatr Blood Cancer. 2017 Oct; 64(10).
Score: 0.015
-
The diagnostic and prognostic value of SALL4 in hepatoblastoma. Histopathology. 2016 Nov; 69(5):822-830.
Score: 0.015